KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exelixis (EXEL) Common Equity: 2009-2025

Historic Common Equity for Exelixis (EXEL) over the last 15 years, with Jan 2025 value amounting to $2.2 billion.

  • Exelixis' Common Equity fell 5.04% to $2.2 billion in Q4 2025 from the same period last year, while for Oct 2025 it was $2.2 billion, marking a year-over-year decrease of 5.04%. This contributed to the annual value of $2.2 billion for FY2025, which is 0.87% down from last year.
  • Per Exelixis' latest filing, its Common Equity stood at $2.2 billion for FY2025, which was down 0.87% from $2.3 billion recorded in FY2023.
  • Exelixis' 5-year Common Equity high stood at $2.5 billion for FY2022, and its period low was $1.9 billion during FY2021.
  • In the last 2 years, Exelixis' Common Equity had a median value of $2.3 billion in 2023 and averaged $2.3 billion.
  • As far as peak fluctuations go, Exelixis' Common Equity increased by 17.64% in 2021, and later declined by 9.02% in 2023.
  • Yearly analysis of 4 years shows Exelixis' Common Equity stood at $1.9 billion in 2021, then grew by 17.64% to $2.2 billion in 2021, then climbed by 12.57% to $2.5 billion in 2022, then fell by 9.02% to $2.3 billion in 2023, then fell by 0.87% to $2.2 billion in 2025.